Filtered By:
Source: Journal of Drugs in Dermatology
This page shows you your search results in order of relevance. This is page number 13.
Order by Relevance | Date
Total 900 results found since Jan 2013.
Treatment of Impetigo and Antimicrobial Resistance
CONCLUSIONS: While published antimicrobial stewardship guidelines have focused on systemic antibiotics, few studies have attempted to evaluate topical antibiotic prescribing practices for impetigo treatment. Many of the topical impetigo treatments currently in use have developed resistance. The appropriate use of topical ozenoxacin can help eradicate impetigo while minimizing AMR.J Drugs Dermatol. 20(4):366-372. doi:10.36849/JDD.5795.PMID:33852242 | DOI:10.36849/JDD.2021.5795
Source: Journal of Drugs in Dermatology - April 14, 2021 Category: Dermatology Authors: Lawrence A Schachner Charles W Lynde Leon H Kircik Antonio Torrelo Daniel Hohl Pearl Kwong Vikash Oza Anneke Andriessen Adelaide A Hebert Source Type: research
A Systematic Review on the Treatment of Dermatosis Papulosa Nigra
J Drugs Dermatol. 2021 Apr 1;20(4):467-472. doi: 10.36849/JDD.2021.5555.ABSTRACTDermatosis papulosa nigra (DPN) is a benign skin condition that is primarily reported in skin of color patients. While prevalent, treatment options are limited and the benign course of DPNs may cause them to be overlooked by clinicians. However, large and multiple lesions in cosmetically sensitive areas may be emotionally and socially distressful to patients. There are few literature reviews examining treatment options for this condition. A literature search was performed using PubMed, Medline, Embase, and Web of Science databases. 67 articles ...
Source: Journal of Drugs in Dermatology - April 14, 2021 Category: Dermatology Authors: Jalal Maghfour Temitayo Ogunleye Source Type: research
Treatment of Impetigo and Antimicrobial Resistance
CONCLUSIONS: While published antimicrobial stewardship guidelines have focused on systemic antibiotics, few studies have attempted to evaluate topical antibiotic prescribing practices for impetigo treatment. Many of the topical impetigo treatments currently in use have developed resistance. The appropriate use of topical ozenoxacin can help eradicate impetigo while minimizing AMR.J Drugs Dermatol. 20(4):366-372. doi:10.36849/JDD.5795.PMID:33852242 | DOI:10.36849/JDD.2021.5795
Source: Journal of Drugs in Dermatology - April 14, 2021 Category: Dermatology Authors: Lawrence A Schachner Charles W Lynde Leon H Kircik Antonio Torrelo Daniel Hohl Pearl Kwong Vikash Oza Anneke Andriessen Adelaide A Hebert Source Type: research
Management of Primary Focal Hyperhidrosis: An Algorithmic Approach
J Drugs Dermatol. 2021 May 1;20(5):523-528. doi: 10.36849/JDD.5774.ABSTRACTHyperhidrosis (HH) is defined as perspiration beyond the level required to maintain temperature regulation. HH affects nearly 4.8% of the population in the United States. It can have a great impact on patient’s quality of life by disturbing daily activity, performance, confidence, social interactions, and mental health. In the majority of patients with HH (93%), the etiology of excess sweating is idiopathic, which classifies it as primary focal HH. Mild HH may be controlled with topical antiperspirants and lifestyle modifications. Based on...
Source: Journal of Drugs in Dermatology - May 3, 2021 Category: Dermatology Authors: Vivian Liu Mehdi Farshchian Geoffrey A Potts Source Type: research
A Systematic Review on the Treatment of Dermatosis Papulosa Nigra
J Drugs Dermatol. 2021 Apr 1;20(4):467-472. doi: 10.36849/JDD.2021.5555.ABSTRACTDermatosis papulosa nigra (DPN) is a benign skin condition that is primarily reported in skin of color patients. While prevalent, treatment options are limited and the benign course of DPNs may cause them to be overlooked by clinicians. However, large and multiple lesions in cosmetically sensitive areas may be emotionally and socially distressful to patients. There are few literature reviews examining treatment options for this condition. A literature search was performed using PubMed, Medline, Embase, and Web of Science databases. 67 articles ...
Source: Journal of Drugs in Dermatology - April 14, 2021 Category: Dermatology Authors: Jalal Maghfour Temitayo Ogunleye Source Type: research
Treatment of Impetigo and Antimicrobial Resistance
CONCLUSIONS: While published antimicrobial stewardship guidelines have focused on systemic antibiotics, few studies have attempted to evaluate topical antibiotic prescribing practices for impetigo treatment. Many of the topical impetigo treatments currently in use have developed resistance. The appropriate use of topical ozenoxacin can help eradicate impetigo while minimizing AMR.J Drugs Dermatol. 20(4):366-372. doi:10.36849/JDD.5795.PMID:33852242 | DOI:10.36849/JDD.2021.5795
Source: Journal of Drugs in Dermatology - April 14, 2021 Category: Dermatology Authors: Lawrence A Schachner Charles W Lynde Leon H Kircik Antonio Torrelo Daniel Hohl Pearl Kwong Vikash Oza Anneke Andriessen Adelaide A Hebert Source Type: research
Management of Primary Focal Hyperhidrosis: An Algorithmic Approach
J Drugs Dermatol. 2021 May 1;20(5):523-528. doi: 10.36849/JDD.5774.ABSTRACTHyperhidrosis (HH) is defined as perspiration beyond the level required to maintain temperature regulation. HH affects nearly 4.8% of the population in the United States. It can have a great impact on patient’s quality of life by disturbing daily activity, performance, confidence, social interactions, and mental health. In the majority of patients with HH (93%), the etiology of excess sweating is idiopathic, which classifies it as primary focal HH. Mild HH may be controlled with topical antiperspirants and lifestyle modifications. Based on...
Source: Journal of Drugs in Dermatology - May 3, 2021 Category: Dermatology Authors: Vivian Liu Mehdi Farshchian Geoffrey A Potts Source Type: research
